Lauréat du Prix Louis-Jeantet de médecine 2017

Les informations ci-après se réfèrent à la date de remise du Prix.

Né en 1968 à Lisbonne, au Portugal, Caetano Reis e Sousa a étudié la biologie à l’Imperial College de Londres, il a obtenu son doctorat en immunologie à Oxford puis a complété sa formation par un travail postdoctoral à l’Institut National de la Santé américain. Revenu au Royaume-Uni en 1998, il a créé un groupe de recherches à l’Imperial Cancer Research Fund, devenu depuis le London Research Institute. En 2015, cet Institut à été intégré au Francis Crick Institute au sein duquel Caetano Reis e Sousa dirige actuellement un groupe de recherches. Il est aussi professeur d’immunologie au département de médecine de l’Imperial College et occupe une chaire d’honneur à l’University College et au King’s College, à Londres.

En 2006, le Professeur Caetano Reis e Sousa a été élu membre de l’Organisation Européenne de Biologie Moléculaire (EMBO) et de l’Académie britannique des sciences médicales. Il a été élevé au rang d’Officier de l’Ordre de Sant’Iago da Espada par son pays natal, le Portugal, en 2009. Il fait partie de l’index Thomson Reuter recensant les chercheurs fréquemment cités dans les revues scientifiques. Il a par ailleurs reçu de nombreuses distinctions, notamment, en 2002, le prix BD Biosciences décerné par la société européenne des macrophages et des cellules dendritiques (EMDS), le prix Liliane Bettencourt pour les sciences du vivant (2008) et le prix pour l’excellence en recherches fondamentales et translationnelles décerné de la Société européenne d’investigation clinique (2011).

Les cellules dendritiques : des détecteurs de pathogènes et des lésions des tissus

Lorsque des agents pathogènes – bactéries, virus ou champignons – pénètrent dans l’organisme, ils provoquent une importante réponse du système immunitaire qui les élimine. Le Professeur Caetano Reis e Sousa a découvert que lorsque des virus ou des champignons pathogènes se retrouvent dans les cellules, ils sont détectés par des capteurs spécifiques qui émettent des signaux déclenchant l’immunité. Il a aussi montré que des filaments d’actine – qui forment le «squelette» des cellules et qui se trouvent mis à nu lorsque la cellule est endommagée et que sa membrane est rompue – peuvent provoquer le même type de réponse. Cela signifie que le système immunitaire répond non seulement aux agents pathogènes, mais aussi à la mort des cellules induite par une infection ou le développement d’un cancer.

De nombreux récepteurs et mécanismes impliqués dans la détection des pathogènes et des cellules mortes sont exprimés par des cellules immunitaires spécialisées, les cellules dendritiques (CD). Caetano Reis e Sousa a contribué à élucider la manière dont les CD intégraient diverses informations sensorielles et coordonnaient la réponse immunitaire. Il a ensuite étudié comment les CD se développaient à partir des progéniteurs des globules blancs présents dans la moelle osseuse et il a identifié un sous-type spécialisé de cellules dendritiques humaines, nommées CD1, qui jouent un rôle essentiel dans l’immunité anticancéreuse et antivirale. Les travaux du Professeur Caetano Reis e Sousa éclairent d’un jour nouveau les mécanismes cellulaires et moléculaires qui sont responsables de la détection, par le système immunitaire, d’une infection ou d’un cancer. Ils ouvrent ainsi la voie au développement de nouveaux vaccins et d’immunothérapies anticancéreuses.

Shorten and reproduced with permission from EMBO Molecular Medicine. Reis e Sousa C (2017) “Sensing infection and tissue damage”. EMBO Mol Med doi:10.15252/emmm.201607227.

Sensing infection and tissue damage

Caetano Reis e Sousa


Innate and adaptive immunity work concertedly in vertebrates to restore homeostasis following pathogen invasion or other insults. Like all homeostatic circuits, immunity relies on an integrated system of sensors, transducers and effectors that can be analysed in cellular or molecular terms. At the cellular level, T and B lymphocytes act as an effector arm of immunity that is mobilised in response to signals transduced by innate immune cells that detect a given insult. These innate cells are spread around the body and include dendritic cells (DCs), the chief immune sensors of pathogen invasion and tumour growth. At the molecular level, DCs possess receptors that directly sense pathogen presence and tissue damage and that signal via transduction pathways to control antigen presentation or regulate a plethora of genes encoding effector proteins that regulate immunity. Notably, molecular circuits for pathogen detection are not confined to DCs or even to immune cells. All cells express sensors and transducers that monitor invasion by viruses and bacteria and elicit suitable effector barriers to pathogen propagation. Here, I discuss work from my laboratory that has contributed to our understanding of these issues over the years.

Cell-intrinsic immunity to RNA viruses

The ability of all nucleated vertebrate cells to respond to virus invasion has been recognised since the discovery of interferons, virus-induced cytokines produced by both immune and nonimmune cells. However, only recently have the relevant sensors and transducers been identified. RNA viruses such as influenza virus replicate using a primer-independent mechanism that leaves a tri-phosphorylated nucleotide at the 5’ end of the genome. The 5’ppp mark is absent from cellular RNAs, which are capped (mRNA) or otherwise processed (rRNA and tRNA). 5’ppp and, for some viruses, 5’pp, therefore acts as a tell-tale sign of RNA virus presence in the cytosol that is recognised, together with elements of RNA secondary structure, by a cytoplasmic protein sensor named RIG-I (Pichlmair et al, 2006; Goubau et al, 2014). A related sensor, MDA5, recognises double stranded (ds) or highly base-paired RNA, which is also often a product of viral replication and is absent from uninfected cells. Following activation by viral RNA, RIG-I and MDA5 engage the mitochondrial adaptor protein MAVS initiating a signal transduction pathway that culminates in activation of transcription factors of the IRF and NF-κB families to induce type I and type III IFN gene expression (Fig. 1). Interestingly, IFNs are not themselves antiviral effectors. Rather, they are secreted by virally infected cells and act in an autocrine and paracrine amplification loop, binding to IFN receptors that signal to induce interferon-stimulated genes (ISGs; Fig. 1). ISGs include the RIG-I and MDA5 sensors themselves, providing a positive feedback loop for innate virus sensing. ISGs also encode a variety of effector proteins that restrict virus propagation by shutting down cell translation, cleaving cellular and viral RNAs and blocking virion replication, assembly and/or release. As such, ISGs encode effectors of antiviral immunity elicited by a simple cell-intrinsic sensing and transducing immune circuit, albeit one involving IFN-mediated amplification and spread (Fig. 1).

Interestingly, the IFN response is absent in invertebrates and plants, which, instead, defend themselves from viruses using RNA interference (RNAi). In those organisms, Dicer enzymes process viral dsRNA to generate small interfering RNA (siRNA) that is loaded onto a complex containing Argonaute proteins that can “slice” viral RNAs bearing complementary sequences. This sequence-specific antiviral RNAi response was thought to have been lost during vertebrate evolution of the IFN response even though the RNAi machinery itself has been preserved and is used for miRNAs generation and action. In fact, sequence-specific antiviral RNAi is not absent in mammals and was recently found to be masked or suppressed by the sequence-unspecific actions of ISG proteins (Maillard et al, 2016). Therefore, RNAi is an antiviral strategy that is preserved from plants to humans and may be important in cellular niches in which the IFN response is attenuated.

Dendritic cells as sensors of viruses and microbes

Viruses have evolved measures to block cell-intrinsic immunity; in vertebrates, innate defences are not sufficient to prevent their spread. We have a sophisticated system of adaptive immune defence that makes use of T and B cells that specifically recognise viruses and other pathogens, as well as commensals, at any body barrier that might be colonised. The T and B cells need to be primed by virus-sensing DCs and RNA viruses present in extracellular spaces can be detected by specialised plasmacytoid DCs using transmembrane receptors of the toll-like receptor (TLR) family such as TLR7 (Diebold et al, 2004). The ligand-binding domain of TLR7 faces the lumen of endosomes and detects the presence of RNA carried by influenza and other RNA viruses that are taken up into those compartments prior to low pH-induced fusion and cytoplasmic entry (Diebold et al, 2004). TLR7 signalling in plasmacytoid DCs results, among others, in the production of type I IFNs that favour priming of antiviral effector T cells. Interestingly, TLR7 recognition, unlike that of RIG-I, does not rely on virus-specific RNA marks and the receptor can be triggered by self RNA artificially delivered to endosomal compartments (Diebold et al, 2004). This argues that pathogen detection can ensue, in some instances, from recognition of molecules shared between invader and host but that become mislocalised in an infectious setting (Diebold et al, 2004). Nevertheless, many TLRs and other innate immune sensing receptors specifically detect molecular signatures of microbes that are qualitatively distinct from those of self. Such receptors include Dectin-1, a transmembrane protein member of the C-type lectin receptor (CLR) family that binds to fungal and bacterial β-1,3-glucans in the extracellular space and endosomes. Dectin-1 possesses a tyrosine-based hemITAM signalling motif in its cytoplasmic tail that becomes phosphorylated by Src family kinases after ligand engagement and serves as a platform for recruiting Syk, a non-receptor tyrosine kinase (Rogers et al, 2005). This initiates a cascade that results in triggering of NF-κB, MAPK and NFAT signalling modules (Fig. 2). DCs activated by Dectin-1 signalling are competent to prime T cells, favouring the induction of Th17 cells, a CD4+ effector T cell type that mediates immunity to fungi and extracellular bacteria (LeibundGut-Landmann et al, 2007).

Detecting damage

Our gut, skin and other barrier surfaces are home to 1-10 times as many bacteria and fungi as our total content of human cells. Yet we do not react to commensals like we do to pathogens despite the fact that they all share the microbial signatures recognised by many innate immune receptors. It is still unclear how our immune system discriminates pathogens from commensals but it is interesting to consider that tissue invasion and disruption are hallmarks of pathogenicity, as they are of malignancy. Interestingly, innate immune cells have receptors that allow detection of cytoplasmic and nuclear components that are exposed or released by damaged cells that have undergone cytopathic insult. One of these, DNGR-1 (a.k.a. CLEC9A), is expressed selectively by DCs and binds to cells that have lost plasma membrane integrity (Sancho et al, 2009). Like Dectin-1, DNGR-1 is a hemITAM-bearing transmembrane CLR that samples the extracellular and endosomal space and signals via Src and Syk (Sancho et al, 2009). Yet DNGR-1 signalling in response to dead cell encounter does not couple to downstream activation of NF-κB (Fig. 2). Rather, it modulates endosomal maturation and has a specialised role in permitting DCs to extract antigens from cell corpses and present them to CD8+ T cells (Sancho et al, 2009). DNGR-1dependent detection of dead cells plays a role in CD8+ T cell responses to cytopathic viruses and, likely, to cancer, in which cell death induced by hypoxia and/or therapy is an important determinant of immunity.

The ability of DNGR-1 to detect dead cells is due to the fact that it binds to F-actin, which is exposed when cells lose plasma membrane integrity (Ahrens et al, 2012). In retrospect, it makes ample sense that exposure of actin, a highly abundant and ubiquitous cytoskeletal protein, should be a target for innate detection of damaged cells. Notably, actin is so conserved that human or mouse DNGR-1 can bind to F-actin from all tested species, from yeast to humans (Ahrens et al, 2012). One might therefore anticipate that extracellular actin sensing preceded the evolution of adaptive immunity and constitutes an ancient mechanism for detecting tissue injury, with its roots perhaps in tissue repair. Consistent with that notion, actin injection into Drosophila melanogaster induces sterile JAK/STAT responses akin to ones previously seen in the context of injury or stress (Srinivasan et al, 2016). Interestingly, although there is no DNGR-1 in Drosophila, the response requires the fly orthologues of Src and Syk arguing for possible evolutionary conservation of the pathway of extracellular actin detection (Srinivasan et al, 2016).

Dendritic cell variety

DCs are part of a broader family of phagocytes that includes monocytes, macrophages and granulocytes. In fact, it is often hard to distinguish DCs from monocytes and macrophages leading to debate over their identity and function. Adding to the confusion, DCs are not one cell type but a family of cells that display similarities but also distinct molecular signatures and ontogenetic dependencies. In the mouse, DNGR-1 is a useful marker of hematopoietic cell commitment to the DC lineage, being first expressed at low levels in DC precursors before they leave the bone marrow and colonise all tissues to give rise to the network of sentinel DCs (Schraml et al, 2013). Therefore, DNGR-1-mediated fate mapping is a powerful means of genetically tracing the DC lineage in vivo (Schraml et al, 2013). However, the receptor is also expressed at much higher levels by a particular sub-type of fully-differentiated DCs known as DC1 that is key for inducing anti-viral and anti-tumour CD8+ T cell responses. Interestingly, preclinical studies suggest that targeting antigens to DC1 via antibodies to DNGR-1 is a promising approach for inducing or boosting anti-tumour immunity. Therefore, receptors utilised by DCs to sense cell damage or pathogens can be useful targets for manipulating the cells in the context of vaccination or immunotherapy. Thus, study of the mechanisms utilised by the immune system to detect pathogens and cell damage not only can lead to basic discoveries but can also have translational application.

figure 1

Figure 1
The IFN pathway of cell-intrinsic antiviral immunity

Different viruses possess or generate RNAs that can be detected by RIG-I and/or MDA5. These sensors transduce signals via the mitochondria-associated MAVS protein that oligomerises and activates TBK-1 and IKKα, IKKβ and IKKε to phosphorylate IRF transcription factor family members (e.g., IRF3 as depicted), as well as IκB to release NF-κB family transcription factors p60 and p65. These transcription factors co-ordinately induce expression of type I and type III IFN and other genes. IFNs are secreted and type I IFNs (IFNα/β) act in autocrine or paracrine manner via the type I IFN receptor (IFNAR) and STAT1/STA2/IRF9 signalling to induce expression of ISGs, the products of which restrict virus infection. P, phosphate group.

figure 1

Figure 2
Role of the Syk-coupled CLRs, Dectin-1 and DNGR-1, in DCs

Dectin-1 and DNGR-1 can both be expressed by DCs. Dectin-1 is monomeric but can oligomerise upon binding to β-glucans exposed by fungal cells. Src family kinases (SFKs) phosphorylate the tyrosine in the YxxL hemITAM motif and allow for docking and activation of Syk, which then signals to NF-κB, MAPK and NFAT resulting in DC activation. In contrast, DNGR-1 is a homodimer stabilised by a disulphide bond in its neck region. Binding of DNGR-1 to F-actin on dead cells also leads to SFK-dependent hemITAM phosphorylation and Syk activation but this does not transmit to NF-κB and does not induce DC activation. Rather, DNGR-1 signalling appears to regulate endosomal maturation to favour presentation of dead cell-associated antigens by MHC class I molecules, a process known as cross-presentation.


  • Ahrens S., et al. (2012). Immunity 36: 635–645
  • Diebold S.S., et al. (2004). Science 303: 1529–1531
  • Goubau D., et al. (2014). Nature 514: 372–375
  • LeibundGut-Landmann S., et al. (2007). Nat Immunol 8: 630–638
  • Maillard P.V., et al. (2016). EMBO J
  • Pichlmair A., et al. (2006). Science 314: 997–1001
  • Rogers N.C., et al. (2005). Immunity 22: 507–517
  • Sancho D., et al. (2009). Nature 458: 899–903
  • Schraml B.U., et al. (2013). Cell 154: 843–858
  • Srinivasan N., et al. (2016). Elife 5

Embo Molecular Medicine

Professeur Caetano Reis e Sousa

The Francis Crick Institute Immunobiology Laboratory
NW205 Room L2-0654
1 Midland Road
London NW1 1AT

Téléphone: +44 20 3796 1310